메뉴 건너뛰기




Volumn 10, Issue 1, 2009, Pages

Building a robust portfolio of new medicines

(1)  Wells, Timothy N C a  

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; AMODIAQUINE PLUS ARTEMISININ; ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ; ARTEMISININ DERIVATIVE; ARTESUNATE; ARTESUNATE PLUS MEFLOQUINE; ARTESUNATE PLUS PYRONARIDINE; CHLOROQUINE; COARSUCAM; DIHYDROARTEMISININ PLUS PIPERAQUINE; EURARTESIM; LEFLUNOMIDE; MALARIA VACCINE; MEFLOQUINE; PYRAMAX; PYRONARIDINE; UNCLASSIFIED DRUG;

EID: 59849102067     PISSN: 14694344     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (1)

References (38)
  • 1
    • 59849111619 scopus 로고    scopus 로고
    • Geneva Switzerland
    • Malaria Report 2008, World Health Organization, Geneva Switzerland http://www.who.int/malaria/wmr2008/malaria2008.pdf.
    • Malaria Report 2008
  • 2
    • 33749266350 scopus 로고    scopus 로고
    • A unified hypothesis for the genesis of cerebral malaria: Sequestration, inflammation and hemostasis leading to microcirculatory dysfunction
    • Nov
    • van der Heyde, HC, Nolan, J, Combes, V, Gramaglia, I, Grau, GE. A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends in Parasitology. 22(11):503-8, 2006 Nov.
    • (2006) Trends in Parasitology , vol.22 , Issue.11 , pp. 503-508
    • van der Heyde, H.C.1    Nolan, J.2    Combes, V.3    Gramaglia, I.4    Grau, G.E.5
  • 3
    • 24044466089 scopus 로고    scopus 로고
    • Colbourne, MJ. Malaria in Gold Coast students on their return from the United Kingdom. Trans R Soc Top Med Hyg 49: 483-487, 1955.
    • Colbourne, MJ. Malaria in Gold Coast students on their return from the United Kingdom. Trans R Soc Top Med Hyg 49: 483-487, 1955.
  • 4
    • 0026728163 scopus 로고
    • Is immunity to malaria really short-lived?
    • Deloron, P, Chougnet, C. Is immunity to malaria really short-lived? Parasitology Today 8: 375-378 1992.
    • (1992) Parasitology Today , vol.8 , pp. 375-378
    • Deloron, P.1    Chougnet, C.2
  • 6
    • 0023110445 scopus 로고
    • The chemistry pharmacology and clinical applications of qinghaosu (artemisinin) and its derivatives
    • Luo, XD, Shen, CC. The chemistry pharmacology and clinical applications of qinghaosu (artemisinin) and its derivatives. Med. Res. Rev. 7 29-52 1987.
    • (1987) Med. Res. Rev , vol.7 , pp. 29-52
    • Luo, X.D.1    Shen, C.C.2
  • 7
    • 0033614329 scopus 로고    scopus 로고
    • Antimalarial drug resistance and combination chemotherapy
    • White, NJ. Antimalarial drug resistance and combination chemotherapy. Philos Trans R Soc Lond B Biol Sci 354: 739-749 1999.
    • (1999) Philos Trans R Soc Lond B Biol Sci , vol.354 , pp. 739-749
    • White, N.J.1
  • 9
    • 56549110631 scopus 로고    scopus 로고
    • Abdulla, S, Sagara, I, Borrmann, S, D'Alessandro, U, Gonzalez, R, Hamel, M, Ogutu, B, Martensson, A, Lyimo, J, Maiga, H, Sasi, P, Nahum, A, Bassat, Q, Juma, E, Otieno, L, Biorkman, A, Beck, HP, Andriano, K, Cousin, M, Lefevre, G, Ubben, D, Premji, Z. Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial. Lancet. 372(9652):1819-27, 2008 Nov 22.
    • Abdulla, S, Sagara, I, Borrmann, S, D'Alessandro, U, Gonzalez, R, Hamel, M, Ogutu, B, Martensson, A, Lyimo, J, Maiga, H, Sasi, P, Nahum, A, Bassat, Q, Juma, E, Otieno, L, Biorkman, A, Beck, HP, Andriano, K, Cousin, M, Lefevre, G, Ubben, D, Premji, Z. Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial. Lancet. 372(9652):1819-27, 2008 Nov 22.
  • 10
    • 59849130099 scopus 로고    scopus 로고
    • www.plos.org/cms/node/208.
  • 11
    • 59849104431 scopus 로고    scopus 로고
    • www.ich.org.
  • 12
    • 59849102224 scopus 로고    scopus 로고
    • http://healthtech.who.int/pq/.
  • 13
    • 59849087274 scopus 로고    scopus 로고
    • http://en.sanofi-aventis.com/binaries/ 081016_coarsucam_who_en_tcm28-22368.pdf.
  • 16
    • 51749098784 scopus 로고    scopus 로고
    • Ramharter, M, Kurth, F, Schreier, AC, Nemeth, J, Glasenapp, I, Belard, S, Schlie, M, Kammer, J, Koumba, PK, Cisse, B, Mordmuller, B, Lell, B, Issifou, S, Oeuvray, C, Fleckenstein, L, Kremsner, Fixed-dose pyronaridine-artesunate combination for treatment of uncomplicated falciparum malaria in pediatric patients in Gabon. [Journal Article. Research Support, Non-U.S. Gov't] Journal of Infectious Diseases. 198(6):911-9, 2008 Sep 15.
    • Ramharter, M, Kurth, F, Schreier, AC, Nemeth, J, Glasenapp, I, Belard, S, Schlie, M, Kammer, J, Koumba, PK, Cisse, B, Mordmuller, B, Lell, B, Issifou, S, Oeuvray, C, Fleckenstein, L, Kremsner, PG. Fixed-dose pyronaridine-artesunate combination for treatment of uncomplicated falciparum malaria in pediatric patients in Gabon. [Journal Article. Research Support, Non-U.S. Gov't] Journal of Infectious Diseases. 198(6):911-9, 2008 Sep 15.
  • 17
    • 59849118131 scopus 로고    scopus 로고
    • www.dndi.org/cms/public_html/ printpage.asp?Articleld=477&Templateld=1.
  • 18
    • 59849124977 scopus 로고    scopus 로고
    • www.who.int/medicines/areas/quality_safety/quality_assurance/ RAJ2006WHOStability.pdf.
  • 19
    • 59849119535 scopus 로고    scopus 로고
    • www.mmv.org/IMG/pdf/PRODUCT_PROFILE_with_logo.pdf.
  • 20
    • 59849091712 scopus 로고    scopus 로고
    • www.mmv.org/IMG/pdf/mmv07_Glance_reoranized_sept2007.pdf.
  • 21
    • 59849118423 scopus 로고    scopus 로고
    • http://prvinfo.org/files/ Biocentury%20-%20Global%20health%20vouchers%202.pdf.
  • 22
    • 59849127645 scopus 로고    scopus 로고
    • Our own estimation of the value of the Priority Review Voucher is based on the real development costs of the product Pyramax Pyronaridine-Artesunate, Using standard probabilities of success for each clinical phase for an anti-infective medicine, and a commercial cost of capital of 12, then we estimate that the voucher would repay the investments needed for all of Phase II and Phase III studies, including the CMC costs. For MMV this is a better description of the value, than giving a pure dollar number, given that the voucher is only useful many years after the clinical development is completed
    • Our own estimation of the value of the Priority Review Voucher is based on the real development costs of the product Pyramax (Pyronaridine-Artesunate). Using standard probabilities of success for each clinical phase for an anti-infective medicine, and a commercial cost of capital of 12%, then we estimate that the voucher would repay the investments needed for all of Phase II and Phase III studies, including the CMC costs. For MMV this is a better description of the value, than giving a pure dollar number, given that the voucher is only useful many years after the clinical development is completed.
  • 26
    • 59849103307 scopus 로고    scopus 로고
    • The attrition rate of 28% from Phase I to launch for anti-infective medicines comes from the Centre for Medicines Research http://cmr.thomsonreuters.com/. We expect this number to fall over the next 10 years, as the number of medicines targeting unprecedented mechanisms increases.
    • The attrition rate of 28% from Phase I to launch for anti-infective medicines comes from the Centre for Medicines Research http://cmr.thomsonreuters.com/. We expect this number to fall over the next 10 years, as the number of medicines targeting unprecedented mechanisms increases.
  • 27
    • 59849110580 scopus 로고    scopus 로고
    • A position paper of the criteria for the selection of partners in a combination therapy against malaria can be found at
    • A position paper of the criteria for the selection of partners in a combination therapy against malaria can be found at http://www.mmv.org/ article.php3?id_article=27.
  • 28
    • 0037015614 scopus 로고    scopus 로고
    • Gardner, MJ, Hall, N, Fung, E, White, O, Berriman, M, Hyman, RW, Carlton, JM, Pain, A, Nelson, KE, Bowman, S, Paulsen, IT, James, K, Eisen, JA, Rutherford, K, Salzberg, SL, Craig, A, Kyes, S, Chan, MS, Nene, V, Shallom, SJ, Suh, B, Peterson, J, Angiuoli, S, Pertea, M, Allen, J, Selengut, J, Haft, D, Mether, MV, Vaiday, AB, Martin, DM, Fairlamb, AH, Fraunholz, MJ, Roos, DS, Ralph, SA, McFadden, GI, Cummings, LM, Subramanian, GM, Mungall, C, Venter, JC, Carucci, DJ, Hoffman, SL, Newbold, C, Davies, RW, Fraser, CM, Barell, B. Genome sequence of the human malaria parasites Plasmodium falciparum. Nature 419 6906 498-511 2002 Oct.
    • Gardner, MJ, Hall, N, Fung, E, White, O, Berriman, M, Hyman, RW, Carlton, JM, Pain, A, Nelson, KE, Bowman, S, Paulsen, IT, James, K, Eisen, JA, Rutherford, K, Salzberg, SL, Craig, A, Kyes, S, Chan, MS, Nene, V, Shallom, SJ, Suh, B, Peterson, J, Angiuoli, S, Pertea, M, Allen, J, Selengut, J, Haft, D, Mether, MV, Vaiday, AB, Martin, DM, Fairlamb, AH, Fraunholz, MJ, Roos, DS, Ralph, SA, McFadden, GI, Cummings, LM, Subramanian, GM, Mungall, C, Venter, JC, Carucci, DJ, Hoffman, SL, Newbold, C, Davies, RW, Fraser, CM, Barell, B. Genome sequence of the human malaria parasites Plasmodium falciparum. Nature 419 6906 498-511 2002 Oct.
  • 29
    • 53649104458 scopus 로고    scopus 로고
    • Carlton, JM, Adams, JH, Silva, JC, Bidwell, SL, Horenzi, H, Caler, E, Crabtree, J, Angiuoli, SV, Merino, EF, Amedeo, P, Chenq, Q, Coulson, RMR, Crabb, BS, del Portillo, HA, Essien, K, Feldblyum, TV, Fernandez-Bacerra, C, Gilson, PR, Gueye, AH, Guo, X, Kang'a, S, Kooij, TWA, Korsinczky, M, Meyer, EVS, Nene, V, Paulsen, I, White, O, Ralph, SA, Ren, Q, Sargeant, TJ, Salzberg, SL, Stoekert, CJ, Sulivan, SA, Yamamoto, MM, Hoffman, SL, Wortman, JR, Gardner, MJ, Galinski, MR, Barnwell, JW, Fraser Liggett, CM. Comparative genomics of the neglected malaria parasite Plasmodium vivax. Nature 455 757-763 2008 October.
    • Carlton, JM, Adams, JH, Silva, JC, Bidwell, SL, Horenzi, H, Caler, E, Crabtree, J, Angiuoli, SV, Merino, EF, Amedeo, P, Chenq, Q, Coulson, RMR, Crabb, BS, del Portillo, HA, Essien, K, Feldblyum, TV, Fernandez-Bacerra, C, Gilson, PR, Gueye, AH, Guo, X, Kang'a, S, Kooij, TWA, Korsinczky, M, Meyer, EVS, Nene, V, Paulsen, I, White, O, Ralph, SA, Ren, Q, Sargeant, TJ, Salzberg, SL, Stoekert, CJ, Sulivan, SA, Yamamoto, MM, Hoffman, SL, Wortman, JR, Gardner, MJ, Galinski, MR, Barnwell, JW, Fraser Liggett, CM. Comparative genomics of the neglected malaria parasite Plasmodium vivax. Nature 455 757-763 2008 October.
  • 30
    • 50849115819 scopus 로고    scopus 로고
    • Plasmodium is haploid for most of its lifecycle, making knock-outs more difficult. The machinery for interference RNA methods has not been conclusively identified in the parasite. More recently, progress has been made using siRNA against potential host targets. Rodriguez, CD, Hannus, M, Prudencio, M, Martin, C, Gonçalves, LA, Portugal, S, Epiphanio, S, Akinc, A, Hadwiger, P, Jahn-Hofmann, K, Röhl, I, Gemert, G-J, Frantich, J-F, Luty, AJF, Sauerwein, R, Mazier, D, Koteliansky, V, Vornlocher, H-P, Echeverin, CJ, Mota, MM. Host Scavenger Receptor SR-BI plays a dual role in the establishment of malaria parasite liver infection. Cell Host & Microbe 4 271-282 2008.
    • Plasmodium is haploid for most of its lifecycle, making knock-outs more difficult. The machinery for interference RNA methods has not been conclusively identified in the parasite. More recently, progress has been made using siRNA against potential host targets. Rodriguez, CD, Hannus, M, Prudencio, M, Martin, C, Gonçalves, LA, Portugal, S, Epiphanio, S, Akinc, A, Hadwiger, P, Jahn-Hofmann, K, Röhl, I, Gemert, G-J, Frantich, J-F, Luty, AJF, Sauerwein, R, Mazier, D, Koteliansky, V, Vornlocher, H-P, Echeverin, CJ, Mota, MM. Host Scavenger Receptor SR-BI plays a dual role in the establishment of malaria parasite liver infection. Cell Host & Microbe 4 271-282 2008.
  • 31
    • 34047255891 scopus 로고    scopus 로고
    • Grundner, C, Perrin, D, Hooft van Huijsduijnen, R, Swinnen, D, Gonzalez, J, Gee, CL, Wells, TN, Alber, T. Structural basis for selective inhibition of Mycobacterium tuberculosis protein tyrosine phosphatase PtpB. [Journal Article. Research Support, N.I.H., Extramural. Research Support, Non-U.S. Gov't. Research Support, U.S. Gov't, Non-P.H.S.] Structure. 15(4):499-509, 2007 Apr.
    • Grundner, C, Perrin, D, Hooft van Huijsduijnen, R, Swinnen, D, Gonzalez, J, Gee, CL, Wells, TN, Alber, T. Structural basis for selective inhibition of Mycobacterium tuberculosis protein tyrosine phosphatase PtpB. [Journal Article. Research Support, N.I.H., Extramural. Research Support, Non-U.S. Gov't. Research Support, U.S. Gov't, Non-P.H.S.] Structure. 15(4):499-509, 2007 Apr.
  • 34
    • 36849021605 scopus 로고    scopus 로고
    • Did they really say... Eradication
    • Nov
    • Roberts, L, Enserink, M. Did they really say... Eradication Science 318 1544-1545 2007 Nov.
    • (2007) Science , vol.318 , pp. 1544-1545
    • Roberts, L.1    Enserink, M.2
  • 35
    • 0037033984 scopus 로고    scopus 로고
    • The economic and social burden of malaria
    • Sachs, J, Malaney, P.The economic and social burden of malaria. Nature 415:680-5 2002.
    • (2002) Nature , vol.415 , pp. 680-685
    • Sachs, J.1    Malaney, P.2
  • 36
    • 33748560490 scopus 로고    scopus 로고
    • Modeling a field trial of the RTS, S/AS02A malaria vaccine
    • See http://www.malariavaccine.org/files/ 20080603_VaccineCongress_Singapore_BOTTING.pdf for a review of the current pipeline, Aug
    • Maire, N, Aponte, JJ, Ross, A, Thompson, R, Alonso, P, Utzinger, J, Tanner, M, Smith, T. Modeling a field trial of the RTS, S/AS02A malaria vaccine. American Journal of Tropical Medicine & Hygiene. 75(2 Suppl):104-10, 2006 Aug. See http://www.malariavaccine.org/files/ 20080603_VaccineCongress_Singapore_BOTTING.pdf for a review of the current pipeline.
    • (2006) American Journal of Tropical Medicine & Hygiene , vol.75 , Issue.2 SUPPL. , pp. 104-110
    • Maire, N.1    Aponte, J.J.2    Ross, A.3    Thompson, R.4    Alonso, P.5    Utzinger, J.6    Tanner, M.7    Smith, T.8
  • 37
    • 33745651114 scopus 로고    scopus 로고
    • The IPTi Consortium: Research for policy and action
    • Jul
    • Schellenberg, D, Cisse, B, Menendez, C. The IPTi Consortium: research for policy and action. Trends in Parasitology. 22(7):296-300, 2006 Jul.
    • (2006) Trends in Parasitology , vol.22 , Issue.7 , pp. 296-300
    • Schellenberg, D.1    Cisse, B.2    Menendez, C.3
  • 38
    • 33846317129 scopus 로고    scopus 로고
    • Reducing the burden of malaria in pregnancy by preventive strategies
    • Feb
    • Menendez, C, D'Alessandro, U, ter Kuile, FO. Reducing the burden of malaria in pregnancy by preventive strategies. The Lancet Infectious Diseases. 7(2):126-35, 2007 Feb.
    • (2007) The Lancet Infectious Diseases , vol.7 , Issue.2 , pp. 126-135
    • Menendez, C.1    D'Alessandro, U.2    ter Kuile, F.O.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.